Department of Radiology

Publications

2023

Holste G, Jiang Z, Jaiswal A, Hanna M, Minkowitz S, Legasto AC, et al. How Does Pruning Impact Long-Tailed Multi-Label Medical Image Classifiers? ArXiv. 2023.

Yang Y, Yang H, Alcaina Y, Puc J, Birt A, Vedvyas Y, et al. Inducible expression of interleukin-12 augments the efficacy of affinity-tuned chimeric antigen receptors in murine solid tumor models. Nat Commun. 2023;14(1):2068.

Tozlu C, Olafson E, Jamison K, Demmon E, Kaunzner U, Marcille M, et al. The sequence of regional structural disconnectivity due to multiple sclerosis lesions. bioRxiv. 2023.

Cau R, Gupta A, Kooi ME, Saba L. Pearls and Pitfalls of Carotid Artery Imaging: Ultrasound, Computed Tomography Angiography, and MR Imaging. Radiol Clin North Am. 2023;61(3):405-413.

Abdel-Rahman SA, Zhang L, Gabr MT. Development of a high-throughput TR-FRET screening assay for LAG-3/FGL1 interaction. SLAS Discov. 2023;28(4):188-192.

Jett S, Boneu C, Zarate C, Carlton C, Kodancha V, Nerattini M, et al. Systematic review of 31P-magnetic resonance spectroscopy studies of brain high energy phosphates and membrane phospholipids in aging and Alzheimer's disease. Front Aging Neurosci. 2023;15:1183228.

Bilgic B, Costagli M, Chan K-, Duyn J, Langkammer C, Lee J, et al. Recommended Implementation of Quantitative Susceptibility Mapping for Clinical Research in The Brain: A Consensus of the ISMRM Electro-Magnetic Tissue Properties Study Group. ArXiv. 2023.

Zhou G, Chen Y, Chien C, Revatta L, Ferdous J, Chen M, et al. Deep learning analysis of blood flow sounds to detect arteriovenous fistula stenosis. NPJ Digit Med. 2023;6(1):163.

Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F, et al. PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023;50(5):1466-1486.

Karbhari A, Mosessian S, Trivedi KH, Valla F, Jacobson M, Truty MJ, et al. Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol. PLoS One. 2023;18(11):e0294564.